Jump to main content
Jump to site search

Issue 71, 2020
Previous Article Next Article

Boosting the abscopal effect of radiotherapy: a smart antigen-capturing radiosensitizer to eradicate metastatic breast tumors

Author affiliations

Abstract

A smart antigen-capturing radiosensitizer based on hollow mesoporous titanium dioxide (HTiO2) has been developed for metastatic breast tumor treatment.

Graphical abstract: Boosting the abscopal effect of radiotherapy: a smart antigen-capturing radiosensitizer to eradicate metastatic breast tumors

Back to tab navigation

Supplementary files

Article information


Submitted
11 Feb 2020
Accepted
20 Jul 2020
First published
21 Jul 2020

Chem. Commun., 2020,56, 10353-10356
Article type
Communication

Boosting the abscopal effect of radiotherapy: a smart antigen-capturing radiosensitizer to eradicate metastatic breast tumors

Y. Chen, W. Pan, P. Gao, M. Shi, T. Wu, N. Li and B. Tang, Chem. Commun., 2020, 56, 10353
DOI: 10.1039/D0CC01080D

Social activity

Search articles by author

Spotlight

Advertisements